BRCA1Mutations in Women Attending Clinics That Evaluate the Risk of Breast Cancer
- 15 May 1997
- journal article
- research article
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 336 (20), 1409-1415
- https://doi.org/10.1056/nejm199705153362002
Abstract
To define the incidence of BRCA1 mutations among patients seen in clinics that evaluate the risk of breast cancer, we analyzed DNA samples from women seen in this setting and constructed probability tables to provide estimates of the likelihood of finding a BRCA1 mutation in individual families.This publication has 24 references indexed in Scilit:
- Growth retardation and tumour inhibition by BRCA1Nature Genetics, 1996
- The complete BRCA2 gene and mutations in chromosome 13q-linked kindredsNature Genetics, 1996
- Identification of the breast cancer susceptibility gene BRCA2Nature, 1995
- Unusual case of Smith‐Lemli‐Opitz syndrome “type II”American Journal of Medical Genetics, 1995
- A Strong Candidate for the Breast and Ovarian Cancer Susceptibility Gene BRCA1Science, 1994
- Localization of a Breast Cancer Susceptibility Gene, BRCA2 , to Chromosome 13q12-13Science, 1994
- Risks of cancer in BRCA1-mutation carriersThe Lancet, 1994
- A comprehensive evaluation of family history and breast cancer risk. The Utah Population DatabaseJAMA, 1993
- Family history, age, and risk of breast cancer. Prospective data from the Nurses' Health StudyJAMA, 1993
- Projecting Individualized Probabilities of Developing Breast Cancer for White Females Who Are Being Examined AnnuallyJNCI Journal of the National Cancer Institute, 1989